Social Media Content Creators Driving Parallel Trade for Unapproved Slimming Drug
A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts directly for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with numerous of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users injecting products of unknown origin.
Several experts stated the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.
Service Response and Content Removal
According to TikTok, the service has removed problematic content and banned related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Investigations also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.
After minutes of entering one community, a vendor shared WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.
Item Details and Costs
Within these groups, messages display dark colored parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram stated it actively monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly significant medical dangers”.
